HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 16 filers reported holding HUMACYTE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14 | +7.7% | 24,195 | -31.2% | 0.00% | – |
| Q4 2022 | $13 | -100.0% | 35,144 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $49,000 | +19.5% | 42,712 | -8.2% | 0.00% | – |
| Q2 2022 | $41,000 | -57.3% | 46,537 | -7.4% | 0.00% | -100.0% |
| Q1 2022 | $96,000 | -20.7% | 50,250 | -5.7% | 0.00% | 0.0% |
| Q4 2021 | $121,000 | -24.4% | 53,274 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $160,000 | – | 54,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RPO LLC | 81,705 | $159,000 | 0.05% |
| CVI Holdings, LLC | 269,138 | $517,000 | 0.03% |
| Sio Capital Management, LLC | 49,998 | $97,000 | 0.03% |
| Alpine Global Management, LLC | 95,000 | $182,000 | 0.02% |
| Exos Asset Management LLC | 27,151 | $53,000 | 0.02% |
| TUDOR INVESTMENT CORP ET AL | 236,549 | $461,000 | 0.01% |
| LMR Partners LLP | 50,000 | $353,000 | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $37,000 | 0.00% |
| Diameter Capital Partners LP | 19,085 | $37,000 | 0.00% |
| HRT FINANCIAL LP | 50,250 | $96,000 | 0.00% |